“Should the definition of CKD be changed to include age-adapted GFR criteria?”: Con: the evaluation and management of CKD, not the definition, should be age-adapted

Andrew S. Levey; Lesley A. Inker; Josef Coresh

doi:10.1016/j.kint.2019.08.032

“Should the definition of CKD be changed to include age-adapted GFR criteria?”: Con: the evaluation and management of CKD, not the definition, should be age-adapted

Andrew S. Levey, Lesley A. Inker, Josef Coresh

Bloomberg School of Public Health

Research output: Contribution to journal › Comment/debate › peer-review

8 Scopus citations

Original language	English (US)
Pages (from-to)	37-40
Number of pages	4
Journal	Kidney international
Volume	97
Issue number	1
DOIs	https://doi.org/10.1016/j.kint.2019.08.032
State	Published - Jan 2020

ASJC Scopus subject areas

Nephrology

Access to Document

10.1016/j.kint.2019.08.032

Cite this

@article{cadb855ebdec4a3d8b2c69fa0490048a,

title = "“Should the definition of CKD be changed to include age-adapted GFR criteria?”: Con: the evaluation and management of CKD, not the definition, should be age-adapted",

author = "Levey, {Andrew S.} and Inker, {Lesley A.} and Josef Coresh",

note = "Funding Information: ASL reports funding to his institute from the National Institutes of Health (NIH). JC reports funding to his institute from the NIH and the National Kidney Foundation (NKF) and is the scientific advisor with Healthy.io. LAI reports funding to her institute from the NIH, NKF, Retrophin Inc., Omeros Corp., Dialysis Inc., and Reata Pharma., and consulting agreements with Tricida Inc. and Omeros Corp. Together they have a provisional patent filed on August 15, 2014: Precise estimation of glomerular filtration rate from multiple biomarkers, patent number PCT/US2015/044567. ",

year = "2020",

month = jan,

doi = "10.1016/j.kint.2019.08.032",

language = "English (US)",

volume = "97",

pages = "37--40",

journal = "Kidney international",

issn = "0085-2538",

publisher = "Elsevier B.V.",

number = "1",

}

TY - JOUR

T1 - “Should the definition of CKD be changed to include age-adapted GFR criteria?”

T2 - Con: the evaluation and management of CKD, not the definition, should be age-adapted

AU - Levey, Andrew S.

AU - Inker, Lesley A.

AU - Coresh, Josef

N1 - Funding Information: ASL reports funding to his institute from the National Institutes of Health (NIH). JC reports funding to his institute from the NIH and the National Kidney Foundation (NKF) and is the scientific advisor with Healthy.io. LAI reports funding to her institute from the NIH, NKF, Retrophin Inc., Omeros Corp., Dialysis Inc., and Reata Pharma., and consulting agreements with Tricida Inc. and Omeros Corp. Together they have a provisional patent filed on August 15, 2014: Precise estimation of glomerular filtration rate from multiple biomarkers, patent number PCT/US2015/044567.

PY - 2020/1

Y1 - 2020/1

UR - http://www.scopus.com/inward/record.url?scp=85076490427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076490427&partnerID=8YFLogxK

U2 - 10.1016/j.kint.2019.08.032

DO - 10.1016/j.kint.2019.08.032

M3 - Comment/debate

C2 - 31901355

AN - SCOPUS:85076490427

SN - 0085-2538

VL - 97

SP - 37

EP - 40

JO - Kidney international

JF - Kidney international

IS - 1

ER -

“Should the definition of CKD be changed to include age-adapted GFR criteria?”: Con: the evaluation and management of CKD, not the definition, should be age-adapted

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this